Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription


1 Brain Res
1 J Abnorm Psychol
1 J Clin Psychiatry
4 J Clin Psychopharmacol
2 PLoS One
3 Psychol Med

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Brain Res

  1. WU D, Lv P, Li F, Zhang W, et al
    Association of peripheral cytokine levels with cerebral structural abnormalities in schizophrenia.
    Brain Res. 2019 Sep 14:146463. doi: 10.1016/j.brainres.2019.146463.
    PubMed     Text format     Abstract available

    J Abnorm Psychol

  2. SPILKA MJ, Pittman DJ, Bray SL, Goghari VM, et al
    Manipulating visual scanpaths during facial emotion perception modulates functional brain activation in schizophrenia patients and controls.
    J Abnorm Psychol. 2019 Sep 19. pii: 2019-54903-001. doi: 10.1037/abn0000468.
    PubMed     Text format     Abstract available

    J Clin Psychiatry

  3. KANE JM, Correll CU
    Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available

    J Clin Psychopharmacol

  4. DUSI N, Comacchio C, Lasalvia A
    Late-Onset Cholestatic Liver Injury During Combination Treatment With Chlorpromazine and Olanzapine: A Case Report.
    J Clin Psychopharmacol. 2019;39:175-176.
    PubMed     Text format    

  5. WAGNER X, Kluge M
    Abrupt Decrease of Clozapine Plasma Concentration After Discontinuation of Flupentixol Comedication.
    J Clin Psychopharmacol. 2019;39:168-169.
    PubMed     Text format    

  6. LEPPLA IE, Nucifora FC, Sedlak TW
    Extended Requirement of Granulocyte Colony-Stimulating Factor for Clozapine-Associated Neutropenia.
    J Clin Psychopharmacol. 2019;39:169-172.
    PubMed     Text format    

  7. KANE JM, Correll CU, Delva N, Gopal S, et al
    Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study.
    J Clin Psychopharmacol. 2019;39:180-182.
    PubMed     Text format    

    PLoS One

  8. ROOSENSCHOON BJ, Kamperman AM, Deen ML, Weeghel JV, et al
    Determinants of clinical, functional and personal recovery for people with schizophrenia and other severe mental illnesses: A cross-sectional analysis.
    PLoS One. 2019;14:e0222378.
    PubMed     Text format     Abstract available

  9. LI F, Sabunciyan S, Yolken RH, Lee D, et al
    Transcription of human endogenous retroviruses in human brain by RNA-seq analysis.
    PLoS One. 2019;14:e0207353.
    PubMed     Text format     Abstract available

    Psychol Med

  10. VASSOS E, Sham P, Kempton M, Trotta A, et al
    The Maudsley environmental risk score for psychosis.
    Psychol Med. 2019 Sep 19:1-8. doi: 10.1017/S0033291719002319.
    PubMed     Text format     Abstract available

  11. QUATTRONE D, Richards A, Reininghaus U, Vassos E, et al
    Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis?
    Psychol Med. 2019 Sep 19:1-4. doi: 10.1017/S0033291719002435.
    PubMed     Text format    

  12. EDWARDS CJ, Garety P, Hardy A
    The relationship between depressive symptoms and negative symptoms in people with non-affective psychosis: a meta-analysis.
    Psychol Med. 2019 Sep 18:1-13. doi: 10.1017/S0033291719002381.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.